Supportive Cancer Care
An Introduction to Supportive Cancer Care
Supportive care is an important area within cancer, aiming to improve the quality of life of patients by treating or preventing symptoms and side effects caused by treatment, whilst providing psychological and social support. Along with advancing treatments to address side effects such as nausea and vomiting, research into complementary and alternative therapies such as yoga and mindfulness is in progress.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Supportive Cancer Care Content
Johan de Munter: Reflections as President of EONS, hopes for 2024 and European Cancer Nursing Day 2023
President of the European Oncology Nursing Society (EONS), Johan de Munter, reflects on his tenure as President, steering the society through the COVID-19 pandemic, his hopes for the society over the next 12 months, including a snapshot into what we can look forward to at the EONS16 annual meeting. Finally, he discusses the these of […]
Trilaciclib: A First-in-class Therapy to Reduce Chemotherapy-induced Myelosuppression
touchREVIEWS in Oncology & Haematology. 2022;18(2):152-8 DOI: https://doi.org/10.17925/OHR.2022.18.2.152
Chemotherapy-induced myelosuppression has long been considered a toxicity that limits the dose of cytotoxic agents, which contributes to significant morbidity and mortality.1 Sub-optimal dose intensity may decrease the efficacy of therapy, thereby compromising progression-free survival (PFS) and overall survival (OS) benefits.2 Chemotherapy-induced myelosuppression is often managed with granulocyte-colony stimulating factors (G-CSFs) and erythropoiesis-stimulating agents (ESAs) […]
Foreword – touchREVIEWS in Oncology & Haematology – VOLUME 18 ISSUE 1 – 2022
Welcome to the latest edition of touchREVIEWS in Oncology & Haematology. Despite the success of the human papillomavirus vaccination programme, cervical cancer remains one of the most common cancers in women, and advanced disease carries a poor prognosis. Lebreton et al. review data from the KEYNOTE-826 Phase III trial, which showed the benefits of adding pembrolizumab […]
Appropriate use of opioids to address cancer-related pain
Three pain specialists consider the use of opioids for the management of cancer-related pain.
- Appraise current best practice for the management of cancer-related pain
- Apply active management of the side effects of opioids in patients with cancer-related pain
- Discuss how to prevent potential risks and abuse of opioids in patients with cancer-related pain
Multidisciplinary management of chronic myeloid leukaemia in the later-line setting: A holistic approach
Watch chronic myeloid leukaemia (CML) specialists within a multidisciplinary team, plus a CML patient advocate, discuss the later-line management of CML.
- Discuss the later-line treatment of chronic myeloid leukaemia, including T315I mutation-positive disease
- Manage the toxicities associated with tyrosine kinase inhibitor treatments for chronic myeloid leukaemia
- Recognize the impact of tyrosine kinase inhibitors on quality of life for patients with chronic myeloid leukaemia
How can shared decision-making be successfully integrated to optimize care of patients with high-risk early breast cancer?
Watch leading breast cancer specialists within an MDT, plus an early breast cancer (EBC) survivor, share their perspectives on shared decision-making (SDM).
- Recognize the importance and relevance of SDM in the context of EBC
- Evaluate the evidence for the effect that SDM has in optimizing outcomes for patients with breast cancer
- Assess the challenges of implementing SDM and formulate strategies to overcome them
Optimizing the patient journey in CSCC through multidisciplinary collaboration
In this activity, leading experts discuss optimal approaches for the management of patients with CSCC and consider how effective multidisciplinary collaboration can contribute to improved outcomes.
- Define multidisciplinary best practices for diagnostic workup of cutaneous squamous cell carcinoma (CSCC) and identification of risk factors influencing prognosis
- Outline interdisciplinary eligibility criteria for surgery and radiotherapy in patients with CSCC
- Determine the optimal use of systemic therapies in patients with unresectable locally advanced or metastatic CSCC and the role of the multidisciplinary tumour board in sharing clinical decisions in cancer care
Personalized treatment of RET-altered thyroid cancers: What is the value of biomarker testing and targeted therapies?
Leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
- Distinguish between different types of thyroid cancers and describe therapies that are appropriate for their management
- Plan a personalized approach to treatment of RET-altered thyroid cancers, including use of biomarker testing and novel targeted therapies
- Evaluate the clinical trial data for novel targeted therapies for RET-altered thyroid cancers and apply it to clinical practice
Foreword – touchREVIEWS in Oncology & Haematology – VOLUME 17 ISSUE 2 – 2021
touchREVIEWS in Oncology & Haematology - 2021;17(2):55
Welcome to the winter edition of touchREVIEWS in Oncology & Haematology. Despite the continued impact of the COVID-19 pandemic on cancer care, 2021 has seen important advances in many areas of oncology, which is reflected in our diverse range of articles. We begin with one of our popular expert interviews, in which Axel Merseburger discusses the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!